Status:
RECRUITING
Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome
Lead Sponsor:
Tanta University
Conditions:
Endocan
Copeptin
Eligibility:
All Genders
28-36 years
Brief Summary
This work aims to investigate and compare the levels of serum endocan and serum copeptin on the first day of life and correlate their levels to the severity of respiratory distress in preterm neonates...
Detailed Description
Preterm birth continues to be one of the significant challenges in perinatal medicine because of its high incidence of morbidities and mortalities. Its burden on the infant, the family, healthcare sys...
Eligibility Criteria
Inclusion
- Prematurity.
- Gestational age between 28 and 36 weeks.
- Suffering from respiratory distress syndrome.
Exclusion
- Intrauterine growth restriction (IUGR).
- Hypoxic ischemic encephalopathy.
- Multiple congenital anomalies.
- Chromosomal abnormalities.
- Preterm less than 28 weeks.
- Neonates with a maternal history of chorioamnionitis (early sepsis).
- Infant of diabetic mother.
- Prelabor rupture of membranes (PROM)\> 2 hours.
Key Trial Info
Start Date :
July 10 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07154134
Start Date
July 10 2025
End Date
November 1 2025
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, El-Gharbia, Egypt, 31527